Sponsors: We’d love to conduct your next Clinical Research Study!
Site Strengths
- *NEW* Onsite Manipulation Suite capable of 8 simultaneous manipulations
- Quality driven team of Research Investigators & Coordinators specializing in diabetes, obesity, MASH and other related conditions (230+ Studies Started)
- Enhanced education services from a Registered Dietician, Certified Diabetes Care & Education Specialist, and Certified Pump Trainer
- *NEW* Dedicated Research Study Startup Specialist
- In-house Marketing & Recruitment teams, with a proprietary database of 25,000 patients
- Patient Referrals through strong Local Provider Partnerships
- Ability to use Central IRB
- Welcoming workspace & amenities for CRAs
Additional Services to Optimize Clinical Trial Enrollment & Retention
With our passion for transforming diabetes and our experience in 230+ drug & device trials, we provide several unique solutions to Sponsors to optimize clinical trial enrollment & retention. Contact us to learn more about our Initial Protocol Reviews, Targeted Marketing, Specialized CRA Training, Consultation Services and more!
Protocol Review Service
Our multidisciplinary team of experts provide pivotal feedback & guidance in the initial stages of protocol development to help Sponsors prevent unnecessary and costly delays throughout the entirety of their clinical study.
Marketing for Sponsors
We offer targeted marketing and lead management to help sponsors find and engage eligible trial participants across the USA. Our digital campaigns and pre-qualification methods streamline recruitment and improve enrollment.
Consultation with Dr. Anuj Bhargava
With 17 years of clinical trial experience and an immense passion for transforming diabetes, Dr. Bhargava has a keen interest in driving therapy (drugs & devices) to the market by guiding Sponsors on successful trial conduct.
CRA & Sponsor Team Member Training/Preceptorship
With real-life, onsite training, we host CRAs or other staff at our center for a two-day workshop and provide them with real-time clinical trial experience.
We are a high-quality institute in Central Iowa performing research in diabetes, obesity, MASH, and more.
Diabetes
- Meds/Insulin
- Continuous Glucose Monitor
- Insulin Pumps
- Frequent Sample Testing
Complications
- Retinopathy
- Kidney Disease
- Cardiovascular Disease
- Neuropathy
Other Conditions
- Obesity
- MASH
- Thyroid Disease
- LP(a)
Testimonials
Recruitment History
Company/Medication | Enrollment Goal | Screened | Randomized | % Enrollment |
---|---|---|---|---|
Medtronic/Pump use in T1D | 12 | 51 | 41 | 342% |
GlaxoSmithKline/CV outcomes | 10 | 31 | 28 | 280% |
Gan and Lee/ Biosimilar insulin glargine in T2D | 12 | 31 | 23 | 192% |
Lilly/T2DM ultra rapid acting formula insulin lispro | 8 | 24 | 13 | 163% |
Gan and Lee/ Biosimilar insulin glargine in T1D | 12 | 27 | 19 | 158% |
Novo Nordisk/GLP-1 use for treatment of obesity | 7 | 16 | 11 | 157% |
Lilly/T1DM ultra rapid acting formula insulin lispro | 13 | 31 | 19 | 146% |
Boehringer Ingelheim/SGLT-2 in T1D | 36 | 50 | 48 | 133% |
Dexcom/CGM use in T1D and T2D | 50 | 59 | 55 | 110% |
Partners We’ve Worked With























